As we reported yesterday, the U.S. Solicitor General, upon request by the Supreme Court, submitted its amicus curiae brief in the hotly-contested False Claims Act case Nathan v. Takeda Pharmaceuticals. As a bit of background, this case involves the practice of off-label marketing, which occurs when a drug company promotes […]
As we have reported in the past, the U.S. Circuit Courts are split on several issues involving the federal False Claims Act. One of the most divisive issues facing the courts today involves the application of Federal Rule of Civil Procedure 9(b). Rule 9(b) requires heightened pleading requirements for plaintiffs […]
In any civil action, a concept known as a statute of limitations applies to limit plaintiffs from filing a lawsuit based on incidents occurring more than a set number of years in the past. For example, personal injury cases carry a two-year statute of limitations in several states (e.g., California, […]
The False Claims Act applies to virtually any intentional submission of a false claim for payment to the federal government. Often times, this involves healthcare fraud and fraud in the defense contracting sector. However, every now and then, a story will emerge involving a less-publicized public entity on the receiving […]
One of the most common practices occurring within the context of healthcare fraud involves a process known as upcoding. When a doctor or nurse performs a medical service, that service corresponds to a universal set of codes used to prepare the patient’s bill. These codes are derived from a compilation […]